Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

PARP inhibitors for prostate cancer: What oncology PAs should know

Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA
PARP inhibitors for prostate cancer: What oncology PAs should know ( Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA )
18 Dec 2020

ESMO 2020: New developments in the treatment of lung cancer

Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2020: New developments in the treatment of lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
17 Dec 2020

SABCS 2020: Conference roundup

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2020: Conference roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
16 Dec 2020

ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma

Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith
ASH 2020:  Immunotherapy in relapsed/refractory multiple myeloma ( Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith )
15 Dec 2020

Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial

Dr Francesca Gay - University of Torino, Torino, Italy
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial ( Dr Francesca Gay - University of Torino, Torino, Italy )
14 Dec 2020

Latest data for managing ALK NSCLC patients

Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea
Latest data for managing ALK  NSCLC patients ( Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea )
11 Dec 2020

ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM

Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA
ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM ( Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA )
9 Dec 2020

MURANO: Sustained disease survival in CLL following venetoclax plus rituximab

Dr Arnon Kater - Cancer Center Amsterdam, Amsterdam, Netherlands
MURANO: Sustained disease survival in CLL following venetoclax plus rituximab ( Dr Arnon Kater - Cancer Center Amsterdam, Amsterdam, Netherlands )
9 Dec 2020

Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk CLL

Dr Lori Leslie - John Theurer Cancer Center, Hackensack, USA
Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk CLL ( Dr Lori Leslie - John Theurer Cancer Center, Hackensack, USA )
9 Dec 2020

OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Dec 2020

Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma

Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma ( Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia )
9 Dec 2020

ASH 2020: Targeted therapies in r/r multiple myeloma

Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Meral Beksaç, Dr Shaji Kumar
ASH 2020: Targeted therapies in r/r multiple myeloma ( Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Meral Beksaç, Dr Shaji Kumar )
8 Dec 2020